Literature DB >> 1904854

Leakage of periplasmic enzymes from envA1 strains of Escherichia coli.

K Young1, L L Silver.   

Abstract

Previous work ascribed antibiotic hypersensitivity of the envA1 mutant to lowered lipopolysaccharide levels and exposure of the lipid bilayer. In the detailed characterization of the EnvA permeability phenotype presented here, the envA1 mutation was shown to confer leakage of the periplasmic enzymes beta-lactamase and RNase I. Leakage was observed in three different genetic backgrounds, including the original envA1 strain and its parent. In contrast, no detectable leakage of the cytoplasmic enzyme beta-galactosidase was observed. Sensitivity of envA1 strains to a range of antibiotics not previously reported was tested, and lipophilicity (partition coefficient) of a number of antibiotics was determined. On the basis of observations of periplasmic leakage and sensitivity to large hydrophilic antibiotics and lysozyme, part of the permeability phenotype of the envA1 mutant is proposed to be due to transient rupture and resealing of the EDTA-sensitive outer membrane layer. In this regard, the EnvA permeability phenotype falls into a general class of permeability/leaky mutants of both Escherichia coli and Salmonella typhimurium.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904854      PMCID: PMC207986          DOI: 10.1128/jb.173.12.3609-3614.1991

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  34 in total

1.  Morphogenesis of the bacterial division septum: a new class of septation-defective mutants.

Authors:  R A Weigand; K D Vinci; L I Rothfield
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

Review 2.  Molecular basis of bacterial outer membrane permeability.

Authors:  H Nikaido; M Vaara
Journal:  Microbiol Rev       Date:  1985-03

3.  Sequence analysis, transcriptional organization, and insertional mutagenesis of the envA gene of Escherichia coli.

Authors:  B Beall; J Lutkenhaus
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

4.  Penicillin resistance in Escherichia coli K12: synergism between penicillinases and a barrier in the outer part of the envelope.

Authors:  H G Boman; K Nordström; S Normark
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

5.  Resistance of Escherichia coli to penicillins. IV. Genetic study of mutants resistant to D,L-ampicillin concentrations o 100 mu-g-ml.

Authors:  H G Boman; K G Eriksson-Grennberg; S Normark; E Matsson
Journal:  Genet Res       Date:  1968-10       Impact factor: 1.588

6.  Mutant of Escherichia coli with anomalous cell division and ability to decrease episomally and chromosomally mediated resistance to ampicillin and several other antibiotics.

Authors:  S Normark; H G Boman; E Matsson
Journal:  J Bacteriol       Date:  1969-03       Impact factor: 3.490

7.  Cell division in a chain-forming envA mutant of Escherichia coli K12. Fine structure of division sites and effects of EDTA, lysozyme and ampicillin.

Authors:  S Normark; H G Boman; G D Bloom
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

8.  Genetic and physiological classification of periplasmic-leaky mutants of Salmonella typhimurium.

Authors:  R A Weigand; L I Rothfield
Journal:  J Bacteriol       Date:  1976-01       Impact factor: 3.490

9.  The relation of the genes envA and ftsA in Escherichia coli.

Authors:  H J Wijsman; C R Koopman
Journal:  Mol Gen Genet       Date:  1976-08-10

10.  Outer membrane of Salmonella typhimurium. Transmembrane diffusion of some hydrophobic substances.

Authors:  H Nikaido
Journal:  Biochim Biophys Acta       Date:  1976-04-16
View more
  27 in total

1.  Escherichia coli strains blocked in Tat-dependent protein export exhibit pleiotropic defects in the cell envelope.

Authors:  N R Stanley; K Findlay; B C Berks; T Palmer
Journal:  J Bacteriol       Date:  2001-01       Impact factor: 3.490

2.  In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates.

Authors:  J Kohler; K L Dorso; K Young; G G Hammond; H Rosen; H Kropp; L L Silver
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 3.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

4.  Multiple antibiotic susceptibility associated with inactivation of the prc gene.

Authors:  A Seoane; A Sabbaj; L M McMurry; S B Levy
Journal:  J Bacteriol       Date:  1992-12       Impact factor: 3.490

5.  Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.

Authors:  Neil Woodford; Philip M Tierno; Katherine Young; Luke Tysall; Marie-France I Palepou; Elaina Ward; Ronald E Painter; Deborah F Suber; Daniel Shungu; Lynn L Silver; Kenneth Inglima; John Kornblum; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

6.  Discovery of FabH/FabF inhibitors from natural products.

Authors:  Katherine Young; Hiranthi Jayasuriya; John G Ondeyka; Kithsiri Herath; Chaowei Zhang; Srinivas Kodali; Andrew Galgoci; Ronald Painter; Vickie Brown-Driver; Robert Yamamoto; Lynn L Silver; Yingcong Zheng; Judith I Ventura; Janet Sigmund; Sookhee Ha; Angela Basilio; Francisca Vicente; José Rubén Tormo; Fernando Pelaez; Phil Youngman; Doris Cully; John F Barrett; Dennis Schmatz; Sheo B Singh; Jun Wang
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 7.  Challenges of antibacterial discovery.

Authors:  Lynn L Silver
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

8.  Kibdelomycin is a bactericidal broad-spectrum aerobic antibacterial agent.

Authors:  Sheo B Singh; Priya Dayananth; Carl J Balibar; Charles G Garlisi; Jun Lu; Ryuta Kishii; Masaya Takei; Yasumichi Fukuda; Sookhee Ha; Katherine Young
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

9.  Inhibitor of intramembrane protease RseP blocks the σE response causing lethal accumulation of unfolded outer membrane proteins.

Authors:  Anna Konovalova; Marcin Grabowicz; Carl J Balibar; Juliana C Malinverni; Ronald E Painter; Daniel Riley; Paul A Mann; Hao Wang; Charles G Garlisi; Brad Sherborne; Nathan W Rigel; Dante P Ricci; Todd A Black; Terry Roemer; Thomas J Silhavy; Scott S Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

10.  Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties.

Authors:  Jun Wang; Srinivas Kodali; Sang Ho Lee; Andrew Galgoci; Ronald Painter; Karen Dorso; Fred Racine; Mary Motyl; Lorraine Hernandez; Elizabeth Tinney; Steven L Colletti; Kithsiri Herath; Richard Cummings; Oscar Salazar; Ignacio González; Angela Basilio; Francisca Vicente; Olga Genilloud; Fernando Pelaez; Hiranthi Jayasuriya; Katherine Young; Doris F Cully; Sheo B Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.